Zimmer Biomet is recalling SpF® PLUS-Mini and SpF XL IIb Implantable Spinal Fusion Stimulators due to potential cytotoxicity issues that were found during routine monitoring.
Bodycad received product notification confirmation which enables them to commercially launch their Unicompartmental Knee System within the European Union.
Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL® viscosupplement for the treatment of knee OA symptoms.